A practical protocol using the polymerase chain reaction (PCR) was designed for detecting Chlamydia trachomatis in clinical samples. DNA was extracted from material collected on urethral swabs and used as substrate for the PCR. The target was a 600 basepair DNA segment of the multicopy plasmid that is common to all strains of the bacterium. Negative samples were checked for loss of DNA or presence of polymerase inhibitors by a second PCR, targeted to a conserved segment of the human genome. The whole procedure was tested on 216 men with nongonococcal urethritis (NGU). All patients were independently assessed by tissue culture isolation (60 positive samples) and a commercial immunoenzymatic assay. The PCR protocol, while sufficiently simple for routine application, was reliable and, for the diagnosis of urethritis, at least as good as tissue culture isolation.
Chlamydia trachomatis causes a wide spectrum of diseases,' and it is very often the cause of non-gonococcal urethritis (NGU). Several procedures for its diagnosis are used in clinical practice,2 but it is widely accepted that a sensitive and at the same time widely available diagnostic assay has yet to be developed. 2 Tissue culture isolation, which is considered the most reliable detection method so far, requires facilities and technical expertise that are not usually available in clinical laboratories. Furthermore, because tissue culture can only detect fully infectious chlamydiae, it is prone to interfering factors2 3 which compromise bacterial viability, usually during specimen collection and storage. There also seems to be a stage during the infection in which the bacterium can be detected using chemical techniques but not by cultural isolation. 4 A diagnostic method based on the extremely sensitive technique of DNA amplification by a polymerase chain reaction (PCR)5 would therefore be very useful and PCR assays for the detection of C trachomatis have been reported recently. " For control PCR, two primers ARI (5'-GGCGGTGACGGAGCTGGGGCG-3') and AR2 (5'-CGCCGCTGCACTGTGAA-GCTC) were synthesised for the specific amplification of a 153 base pair segment of the DR-f genes, in the HLA-class II region.'0 The segment corresponds to amino acid residues 49 to 94, encoded by the second exon of the DR genes.'0 AR1-AR2 can amplify all known alleles of these genes; they were used in the same experimental conditions described above for PCR with Champ 1/4 primers.
The clinical specimens were taken from 17 to 37 year old men, attending the hospital's sexually transmitted diseases clinic, who presented with symptoms broadly grouped as "urethritis". These were as follows: dysuria, or urethral discharge, or a Gram stained smear showing four or more polymorphonuclear lymphocytes per microscopic field ( x 1000 magnification) and severity of symptoms were variable; information on the sexual behaviour of patients was not collected. Within this group 216 consecutive samples negative for gonococcal isolation, performed according to the Biocult-GC method (Orion Diagnostica, Espoo, Finland), were classified as NGU and were examined for chlamydial infection.
Specimens were obtained as endourethral cotton swabs. These were immersed in the appropriate medium or buffer in a sterile phial containing two small glass beads. After about an hour at room temperature and vortexing for one minute the swab was squeezed and withdrawn.
The enzyme linked immunoassay Chlamydiazyme (Abbott, Chicago, Illinois, USA) was performed according to the manufacturer's instructions.
Tissue culture was performed within a few hours of sample collection. McCoy cell monolayers treated with cycloheximide and a fluorescein labelled, species specific monoclonal antibody against major outer membrane protein were used as previously described. '5 Swab material was dispersed, as described above, in 0-8 ml of lysis buffer (10 mM TRIS-HCI, pH 7 
Results
The PCR was targeted to the C trachomatis common plasmid" 12-'4 and was initially tested using several kinds of samples prepared in the laboratory. These contained either 0 1-1 pg of pUC8-PCTD, a recombinant pUC8 plasmid comprising the entire chlamydial plasmid (serotype D variant'4), or 10-100 ng of nucleic acids extracted from infected HeLa cells, or pUC8-PCTD added to 1 pg of human lymphocyte DNA. Samples of total nucleic acids extracted from urethral swabs of infected patients were also used for PCR optimisation.
Different primer hybridisation temperatures, Mg' -, and primer concentrations were tested on several types of samples (data not shown). For positive clinical samples the Mg optimal concentration, with 1 ,uM Champl /4 primers, was close to 1 5 mM. PCR conditions were eventually standardised.
Normally a single major electrophoretic band of the expected size (about 600 base pairs) was obtained (figure) with no interfering artefactual PCR products; only occasionally with some clinical samples could a few background bands be observed. The identity of the amplified DNA segment was confirmed by hybridisation with Champ3, 5' end-labelled with 32P, on Southern blots" or in a dot-blot assay (results not shown). was not directly estimated, but C trachomatis negative samples were further assessed by amplifying a conserved DNA segment of human DNA: this ensured presence of adequate amounts of DNA in the sample and absence of polymerase inhibitors or nuclease contamination-that is, correct processing of the specimen. (3) The PCR was limited to 30 cycles and scoring was done on one fifth of the amplified sample, on the basis of presence or absence of a single electrophoretic band, about 600 base pairs in length and clearly detectable by ethidium bromide fluorescence.
This protocol was assessed on 216 consecutive cases of NGU. Three specimens were collected from each patient and assessed in parallel by Chlamydiazyme immunoassay, cultural isolation, and PCR. For ethical and technical reasons, each test was performed on a different specimen rather than dividing each sample into three parts. The specimen for the PCR test was the last; all the material from the first two swabs was used for the officially approved diagnostic tests.
Typical positive and negative PCR results are shown in the figure. All C trachomatis negative samples produced an intense electrophoretic band when amplified with the HLA control primers ( figure, lanes 6, 7) . The results are summarised in tables 1 and 2.
Discussion
The PCR followed by detection with ethidium bromide fluorescence (ETB-PCR) yielded a single electrophoretic DNA band which correlated with the presence of the chlamydial common plasmid in the sample. The assay permitted a detection limit of the order of 103 target molecules per sample before amplification. This can be assumed to correspond to 102 chlamydiae.'2 In other words, if performed on one fifth ofDNA extracted from a clinical swab, the ETB-PCR permits detection of about 500 bacteria in the whole sample-a figure compatible with one chlamydial cytoplasmic inclusion of average size, even allowing for loss of DNA during sample extraction.
Greater sensitivity may be achieved by increasing the number of cycles and adopting more sensitive detection methods, such as using a "2P-labelled probe. This was not attempted, however, as such procedures would not be convenient for routine diagnosis, which was our primary interest. Furthermore, detection of a very low number of target molecules (1000 to 1) may require a greater degree of sample manipulation for reliability-for example, reagent variation during PCR"7 or testing each sample multiply to compensate for the random nature of early events.5 In the absence of full automation this is also undesirable because it increases the chance of sample contamination, probably the major problem in PCR when used for diagnosis.
In previous reports PCRs for the detection of C trachomatis were targeted to a conserved segment of the chromosomal MOMP gene,7 or to a ribosomal RNA gene,8 or to the 7-5 kilo base common plasmid.9 Reported PCR sensitivities varied from as low as 106-107 elementary bodies7 to as high as 10-'7g (with 40 PCR cycles) of total chlamydial DNA,9 showing detection on laboratory samples of amounts of total chlamydial DNA equivalent to one plasmid molecule, or even less. The random behaviour of PCR at such extreme target dilutions is not discussed, and some of the data seem to imply a target amplification close to These considerations explain the choice of initially assessing the reliability of the PCR protocol on a group of NGU cases of variable severity, for which cultural isolation was likely to be sufficiently close to a real "goldstandard". With other diseases, in which cultural isolation has a poor performance-for example, 50% sensitivity reported for ocular specimens4 -or, when chlamydial infection is suspected but isolation is usually negative, a good PCR test would be expected to detect the pathogen unlike other tests and in the absence of a recognised standard. It is therefore our opinion that such studies represent an important goal for PCR diagnosis, but procedures should first be assessed in a safer context, like the one reported here.
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